IL6 and inflammatory bowel disease: High concentrations or certain structural forms may increase cytokine production (e.g., IL-6, TNF-α) in immune cells, potentially exacerbating inflammation in conditions like inflammatory bowel disease (IBD) depending on concentration and the inflammatory environment.